These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 190513

  • 21. Evaluation of peripheral dopamine receptor and alpha-adrenoceptor blocking activity of sulpiride.
    Barrett RJ, Ginos JZ, Lokhandwala MF.
    Eur J Pharmacol; 1982 Apr 23; 79(3-4):273-81. PubMed ID: 6124431
    [Abstract] [Full Text] [Related]

  • 22. Adrenergic mechanisms in postvagal tachycardia.
    Loeb JM, Vassalle M.
    J Pharmacol Exp Ther; 1979 Jul 23; 210(1):56-63. PubMed ID: 448648
    [Abstract] [Full Text] [Related]

  • 23. Vascular and cardiac actions of N-di-alkyl dopamine analogs.
    Long JP, Gebhart GF, Flynn JR, Cannon JG.
    Arch Int Pharmacodyn Ther; 1980 May 23; 245(1):104-17. PubMed ID: 7406595
    [Abstract] [Full Text] [Related]

  • 24. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I, Lefèvre-Borg F, Gomeni R.
    J Pharmacol Exp Ther; 1981 Aug 23; 218(2):515-24. PubMed ID: 7252851
    [Abstract] [Full Text] [Related]

  • 25. Responses of the canine hepatic arterial and portal venous vascular beds to dopamine.
    Richardson PD, Withrington PG.
    Eur J Pharmacol; 1978 Apr 15; 48(4):337-49. PubMed ID: 206449
    [Abstract] [Full Text] [Related]

  • 26. Dopaminergic activity of cis-trans isomers of benzhydro[f]quinoline analogs.
    Verimer T, Long JP, Rusterholz DR, Flynn JR, Cannon JG, Lee T.
    Eur J Pharmacol; 1980 Jun 27; 64(4):271-7. PubMed ID: 7389823
    [Abstract] [Full Text] [Related]

  • 27. Studies on the hypotensive action of alpha-methyldopamine.
    Finch L, Hersom A, Hicks P.
    Br J Pharmacol; 1975 Aug 27; 54(4):445-51. PubMed ID: 1100157
    [Abstract] [Full Text] [Related]

  • 28. Cardiovascular effects of intracerebroventricular injection of dopamine after selective MAO inhibition in rats.
    Pazos A, Mediavilla A, Flórez J.
    Neuropharmacology; 1982 Apr 27; 21(4):317-22. PubMed ID: 6283412
    [Abstract] [Full Text] [Related]

  • 29. [Action of N-butylnorsympathone on the effects of cardioaccelerator nerve stimulation in the dog].
    Mouillé P, Huchet AM, Chelly J, Schmitt H.
    C R Seances Acad Sci D; 1979 Feb 05; 288(5):551-4. PubMed ID: 35285
    [Abstract] [Full Text] [Related]

  • 30. Effects of some dopamine analogs and haloperidol on response to stimulation of adrenergic nerves using cat atria in vitro.
    Ilhan M, Long JP, Cannon JG.
    Arch Int Pharmacodyn Ther; 1976 Feb 05; 219(2):193-204. PubMed ID: 1275615
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular responses produced by the injection of dopamine into the cerebral ventricles of the unanaesthetized dog.
    Lang WJ, Woodman OL.
    Br J Pharmacol; 1979 Jun 05; 66(2):235-40. PubMed ID: 465876
    [Abstract] [Full Text] [Related]

  • 32. The reversal by metoclopramide of apomorphine-induced inhibition of responses to stimulation of the cardioaccelerator nerves in the cat.
    Tuncer M.
    Indian J Physiol Pharmacol; 1984 Jun 05; 28(1):15-20. PubMed ID: 6490125
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of cardiac sympathetic neurotransmission by adenosine.
    Lokhandwala MF.
    Eur J Pharmacol; 1979 Dec 20; 60(4):353-7. PubMed ID: 230983
    [Abstract] [Full Text] [Related]

  • 34. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves.
    de Champlain J, Nadeau R.
    Fed Proc; 1971 Dec 20; 30(3):877-85. PubMed ID: 4324975
    [No Abstract] [Full Text] [Related]

  • 35. Dopamine and lumbar ganglionic transmission in the dog.
    Willems JL, Haszowska-Owczarek A, Bogaert MC.
    Arch Int Pharmacodyn Ther; 1972 Apr 20; 196():Suppl 196:315+. PubMed ID: 4340734
    [No Abstract] [Full Text] [Related]

  • 36. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.
    Willems JL, Buylaert WA, Lefebvre RA, Bogaert MG.
    Pharmacol Rev; 1985 Jun 20; 37(2):165-216. PubMed ID: 2996038
    [No Abstract] [Full Text] [Related]

  • 37. [Mechanism of action of ibopamine: pharmacological effects of epinine and other metabolites].
    Ferrini R, Merlo L, Miragoli G.
    Cardiologia; 1988 Jan 20; 33(1):49-53. PubMed ID: 2835159
    [No Abstract] [Full Text] [Related]

  • 38. Role of the sympathetic nervous system in the cardiovascular effects of cocaine.
    Gillis RA, Bachenheimer LC, Dretchen KL, Erzouki HK, Hernandez YM, Jain RK, Jain MK, Kuhn FE, Quest J, Schaer GL.
    NIDA Res Monogr; 1991 Jan 20; 108():92-109. PubMed ID: 1749420
    [No Abstract] [Full Text] [Related]

  • 39. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF, Buckley JP.
    J Pharmacol Exp Ther; 1978 Feb 20; 204(2):362-71. PubMed ID: 621670
    [No Abstract] [Full Text] [Related]

  • 40. Failure of beta-adrenergic receptor blockade to prevent arrhythmias induced by sympathetic nerve stimulation.
    Gillis RA, Pearle DL, Hoekman T.
    Science; 1974 Jul 05; 185(4145):70-2. PubMed ID: 4151754
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.